A 20S Complex Containing CDC27 and CDC16 Catalyzes the Mitosis-Specific Conjugation of Ubiquitin to Cyclin B

Total Page:16

File Type:pdf, Size:1020Kb

A 20S Complex Containing CDC27 and CDC16 Catalyzes the Mitosis-Specific Conjugation of Ubiquitin to Cyclin B Cell, Vol. 81,279-288, April 21, 1995, Copyright© 1995 by Cell Press A 20S Complex Containing CDC27 and CDC16 Catalyzes the Mitosis-Specific Conjugation of Ubiquitin to Cyclin B Randall W. King,*t Jan-Michael Peters,*t cyclin degradation is required to exit mitosis (Surana et Stuart Tugendreich,$ Mark Rolfe,§ Philip Hieter,$ al., 1993; Holloway et al., 1993). Treatments that interfere and Marc W. Kirschnert with the proteolysis of endogenous cyclin B, however, ar- tDepartment of Cell Biology rest cell division earlier, at anaphase (Holloway et al., Harvard Medical School 1993). This discrepancy can be explained by hypothesiz- Boston, Massachusetts 02115 ing that chromosome segregation and cyclin proteolysis $Department of Molecular Biology and Genetics depend upon common components. Support for this idea Johns Hopkins School of Medicine has emerged recently from studies in budding yeast, in Baltimore, Maryland 21205 which CDC16 and CDC23, genes required for progression §Mitotix, Incorporated through anaphase, have been shown to be required for One Kendall Square the proteolysis of B-type cyclins (Irniger et al., 1995 [this Cambridge, Massachusetts 02139 issue of Cell]). The proteins encoded by these genes form a complex with the CDC27 protein (Lamb et al., 1994), a homolog of which is also required for anaphase progres- Summary sion in mammalian cells (Tugendreich et al., 1995 [this issue of Cell]). Cyclin B is degraded at the onset of anaphase by a Biochemical evidence suggests that cyclin proteolysis ubiquitin-dependent proteolytic system. We have frac- is mediated by the ubiquitin pathway: cyclin B-ubiquitin tionated mitotic Xenopus egg extracts to identify com- conjugates can be observed in mitotic, but not interphase, ponents required for this process. We find that UBC4 Xenopus extracts (Glotzer et al., 1991); mutations in the and at least one other ubiquitin-conjugating enzyme D box that block degradation also interfere with ubiquitina- can support cyclin B ubiquitination. The mitotic speci- tion (Glotzer et al., 1991); and methylated ubiquitin, an ficity of cyclin ubiquitination is determined by a 20S inhibitor of polyubiquitin chain formation, interferes with ~omplex that contains homologs of budding yeast the proteolysis of A- and B-type cyclins in extracts of clam CDC16 and CDC27, Because these proteins are re- eggs (Hershko et al., 1991). quired for anaphase in yeast and mammalian cells, we A complex multistep pathway is required for the covalent refer to this complex as the anaphase-promoting com- attachment of polyubiquitin chains to substrate proteins plex (APC). CDC27 antibodies deplete APC activity, (reviewed by Ciechanover, 1994). The polypeptide ubiqui- while immunopurified CDC27 complexes are sufficient tin is first activated at its C-terminus via thioester formation to complement either interphase extracts or a mixture with El, the ubiquitin-acti~ating enzyme. E1 subsequently of recombinant UBC4 and the ubiquitin-activating en- transfers ubiquitin to a family of ubiquitin-conjugating en- zyme El. These results suggest that APC functions as zymes (E2s), again forming thioester intermediates. Al- a regulated ubiquitin-protein ligase that targets cyclin though certain E2s can transfer ubiquitin directly to sub- B for destruction in mitosis. strates in vitro, the physiologic reaction often requires a third component, termed a ubiquitin-protein ligase or E3. Introduction This component can directly mediate substrate specificity and may also be required to synthesize the polyubiquitin Entrance into mitosis is governed by the protein kinase chain that is presumed to target the substrate for degrada- Cdc2, whose positive regulatory subunits, the mitotic tion by the 26S proteasome complex (reviewed by Peters, cyclins, accumulate throughout interphase. Exit from mito- 1994). In certain cases, substrate specificity is mediated sis requires the inactivation of Cdc2, initiated by rapid by an additional component, such as the human papillo- cyclin B proteolysis that commences at anaphase. Resta- mavirus E6 protein, which interacts with a cellular E3 to bilization in the subsequent interphase enables cyclin B ubiquitinate p53 (Scheffner et al., 1993). to accumulate again, initiating a new mitotic cycle. In the The cyclin ubiquitination reaction is unusual in that it embryonic cell cycle, the regulated activation and inactiva- exhibits specificity at two levels: substrate recognition, tion of mitotic cyclin destruction transforms continuous which is reflected in the requirement for an intact D box, cyclin synthesis into alternating periods of interphase and and temporal control in the limitation of its activity to a mitosis (reviewed by Nasmyth, 1993; King et al., 1994). specific phase of the cell cycle, late mitosis and early G1 Mitotic cyclins contain a short N-terminal sequence, (Hunt et al., 1992; Amon et al:,, 1994). Little is known re- called the destruction box (D box), that is required for their garding the components involved in cyclin B ubiquitina- rapid degradation (Glotzer et a!., 1991). Ectopic expres- tion. Studies in budding yeast have implicated a ubiquitin- sion of nondegradable cyclins arrests the cell cycle with conjugating enzyme, UBC9, in the degradation of both S elevated levels of Cdc2 kinase activity (Murray et al., 1989; and M phase cyclins (Seufert et al., 1995); however, it Ghiara et al., 1991; Luca et al., 1991; Gallant and Nigg, remains unclear whether this enzyme is required for D 1992). This arrest occurs in telophase, suggesting that box-dependent ubiquitination. Fractionation of clam egg extracts has separated two activities distinct from E1 that *These authors contributed equallyto this work. are required for cyclin ubiquitination (Hershko et al., 1994). Cell 280 A Mitotic Extract that it functions as a temporally regulated cyclin-ubiquitin ligase. Peliet Membranest Supernatant 1 Flow L~J O.l-O.6 M Results , through | KCI gradient Q1 Q'2 Cyclin Ubiquitination Activity Requires Both Cell [~ 0'2M I 0"4M Flow 0.6 M KCI KCI Cycle-Regulated and Unregulated Fractions throughIKCt eluate I I , --1 ~ As a substrate for the cyclin ubiquitination reaction, an Q1A QIB iodinated N-terminal fragment of sea urchin cyclin B was used. We monitored the formation of radiolabeled cyclin- B C D E ubiquitin conjugates by SDS-polyacrylamide gel electro- C phoresis (SDS-PAGE) and autoradiography. The ubiquiti- OO OOOO OOO nation and degradation of this protein are dependent upon o ++ ++++ +E++E+ the cell cycle state of crude extracts and require an intact o_~ 58oo 0006 oooa D box (Holloway et al., 1993; data not shown). As a source of factors required for cyclin ubiquitination, concentrated interphase extracts from Xenopus eggs were prepared. Stable mitotic extracts that constitutively degrade cyclin B were then obtained by addition of the nondegradable cyclin B A90 fragment (Glotzer et al., 1991). Our fractionation protocol is shown sche m atically in Fig- ure 1A. As a first step, we prepared pellet, membrane, [12~ and supernatant ($100) fractions by high speed centrifu- gation of diluted crude mitotic extracts. Cyclin ubiquitina- Figure 1. Fractionation of Cyclin Ubiquitination Activity in Mitotic tion activity was recovered in the $100 fraction after recon- Xenopus Egg Extracts into a Regulated and an Unregulated Fraction centration to the original volume, as indicated by the (A) Fractionation scheme. For details see Results. ladder-like appearance of higher molecular mass species (13) Pellet (P), membrane (M), and supernatant ($100) fractions ob- (Figure 1B). Ubiquitin conjugates were observed within tained from mitotic extracts were assayed for their ability to convert a radiolabeled N-terminalfragment of cyclin B ([1251]cyc)into ubiquitin 1-2 min of incubation in the mitotic supernatant and conjugates. reached a steady state within 5 min (data not shown). The (C) Flowthrough (Q1) and eluate (Q2) fractions were obtained from substrate was degraded in this fraction with a half-life of mitotic $100 by ResourceQ chromatographyand assayedindividually 5 rain, similar to that observed in crude extracts (data not or after mixing equal volumes. D box dependencewas tested by addi- shown). No ubiquitination activity was detectable in the tion of a radiolabeledfragment containingtwo D box point mutations (lane marked Q1 plus Q2 with an asterisk). washed pellet or membrane fractions (Figure 1B). (D) Flowthrough(Q1 ~) and eluate (Q2i) fractions were prepared as in We fractionated mitotic $100 by anion exchange chro- (C) using interphase $100 and were tested for their ability to replace matography, using Resource Q as a resin, yielding a Q1 and Q2 derived from mitotic $100. flowthrough fraction (Q1) and a 0.6 M KCI eluate (Q2). (El Fractions Q1 and Q2 were immunodepleted with either purified total mouse IgG control antibody(Q1 c and Q2~) or with purified MPM-2 While neither fraction alone catalyzed cyclin ubiquitina- monoclonal antibody (Qlr" and Q2m) and assayed as in (C). tion, mixing the fractions fully reconstituted activity (Figure 1C). A substrate containing a mutated D box (R42A and A44R) produced only low molecular mass conjugates. To determine whether both of these fractions were mitotically While one activity is found only in mitotic extracts, the regulated, we prepared Q1 and Q2 from interphase $100 other is active throughout the cell cycle and appears to (designated Q1 ~ and Q2~). Cyclin ubiquitination was ob- be an E2. The components required for D box-dependent sewed when Q1 was replaced by Q1 ~, but
Recommended publications
  • A New Genetic Method for Isolating Functionally Interacting Genes
    Copyright 2000 by the Genetics Society of America A New Genetic Method for Isolating Functionally Interacting Genes: High plo1؉-Dependent Mutants and Their Suppressors De®ne Genes in Mitotic and Septation Pathways in Fission Yeast C. Fiona Cullen,*,² Karen M. May,* Iain M. Hagan,³ David M. Glover²,§ and Hiroyuki Ohkura*,² *Institute of Cell and Molecular Biology, The University of Edinburgh, Edinburgh EH9 3JR, United Kingdom, ²Department of Anatomy and Physiology, Medical Sciences Institute, The University of Dundee, Dundee DD1 4HN, United Kingdom, ³School of Biological Sciences, The University of Manchester, Manchester M13 9PT, United Kingdom and §Department of Genetics, University of Cambridge, Cambridge CB2 3EH, United Kingdom Manuscript received February 2, 2000 Accepted for publication April 10, 2000 ABSTRACT We describe a general genetic method to identify genes encoding proteins that functionally interact with and/or are good candidates for downstream targets of a particular gene product. The screen identi®es mutants whose growth depends on high levels of expression of that gene. We apply this to the plo1ϩ gene that encodes a ®ssion yeast homologue of the polo-like kinases. plo1ϩ regulates both spindle formation and septation. We have isolated 17 high plo1ϩ-dependent (pld) mutants that show defects in mitosis or septation. Three mutants show a mitotic arrest phenotype. Among the 14 pld mutants with septation defects, 12 mapped to known loci: cdc7, cdc15, cdc11 spg1, and sid2. One of the pld mutants, cdc7-PD1, was selected for suppressor analysis. As multicopy suppressors, we isolated four known genes involved in septation in ®ssion yeast: spg1ϩ, sce3ϩ, cdc8ϩ, and rho1ϩ, and two previously uncharacterized genes, mpd1ϩ and mpd2ϩ.
    [Show full text]
  • Analysis of Gene Expression Data for Gene Ontology
    ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins.
    [Show full text]
  • New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology
    Cancer Research and Treatment 2003;35(4):304-313 New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology Yong-Wan Kim, Ph.D.1, Min-Je Suh, M.S.1, Jin-Sik Bae, M.S.1, Su Mi Bae, M.S.1, Joo Hee Yoon, M.D.2, Soo Young Hur, M.D.2, Jae Hoon Kim, M.D.2, Duck Young Ro, M.D.2, Joon Mo Lee, M.D.2, Sung Eun Namkoong, M.D.2, Chong Kook Kim, Ph.D.3 and Woong Shick Ahn, M.D.2 1Catholic Research Institutes of Medical Science, 2Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul; 3College of Pharmacy, Seoul National University, Seoul, Korea Purpose: This study utilized both mRNA differential significant genes of unknown function affected by the display and the Gene Ontology (GO) analysis to char- HPV-16-derived pathway. The GO analysis suggested that acterize the multiple interactions of a number of genes the cervical cancer cells underwent repression of the with gene expression profiles involved in the HPV-16- cancer-specific cell adhesive properties. Also, genes induced cervical carcinogenesis. belonging to DNA metabolism, such as DNA repair and Materials and Methods: mRNA differential displays, replication, were strongly down-regulated, whereas sig- with HPV-16 positive cervical cancer cell line (SiHa), and nificant increases were shown in the protein degradation normal human keratinocyte cell line (HaCaT) as a con- and synthesis. trol, were used. Each human gene has several biological Conclusion: The GO analysis can overcome the com- functions in the Gene Ontology; therefore, several func- plexity of the gene expression profile of the HPV-16- tions of each gene were chosen to establish a powerful associated pathway, identify several cancer-specific cel- cervical carcinogenesis pathway.
    [Show full text]
  • Mouse Cdc27 Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Cdc27 Knockout Project (CRISPR/Cas9) Objective: To create a Cdc27 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Cdc27 gene (NCBI Reference Sequence: NM_145436 ; Ensembl: ENSMUSG00000020687 ) is located on Mouse chromosome 11. 19 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 19 (Transcript: ENSMUST00000093923). Exon 2~7 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 2 starts from about 1.13% of the coding region. Exon 2~7 covers 32.93% of the coding region. The size of effective KO region: ~8408 bp. The KO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 6 7 19 Legends Exon of mouse Cdc27 Knockout region Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 2 is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 1285 bp section downstream of Exon 7 is aligned with itself to determine if there are tandem repeats.
    [Show full text]
  • Genetic and Genomic Analysis of Hyperlipidemia, Obesity and Diabetes Using (C57BL/6J × TALLYHO/Jngj) F2 Mice
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Nutrition Publications and Other Works Nutrition 12-19-2010 Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P. Stewart Marshall University Hyoung Y. Kim University of Tennessee - Knoxville, [email protected] Arnold M. Saxton University of Tennessee - Knoxville, [email protected] Jung H. Kim Marshall University Follow this and additional works at: https://trace.tennessee.edu/utk_nutrpubs Part of the Animal Sciences Commons, and the Nutrition Commons Recommended Citation BMC Genomics 2010, 11:713 doi:10.1186/1471-2164-11-713 This Article is brought to you for free and open access by the Nutrition at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Nutrition Publications and Other Works by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. Stewart et al. BMC Genomics 2010, 11:713 http://www.biomedcentral.com/1471-2164/11/713 RESEARCH ARTICLE Open Access Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P Stewart1, Hyoung Yon Kim2, Arnold M Saxton3, Jung Han Kim1* Abstract Background: Type 2 diabetes (T2D) is the most common form of diabetes in humans and is closely associated with dyslipidemia and obesity that magnifies the mortality and morbidity related to T2D. The genetic contribution to human T2D and related metabolic disorders is evident, and mostly follows polygenic inheritance. The TALLYHO/ JngJ (TH) mice are a polygenic model for T2D characterized by obesity, hyperinsulinemia, impaired glucose uptake and tolerance, hyperlipidemia, and hyperglycemia.
    [Show full text]
  • WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2019/079361 Al 25 April 2019 (25.04.2019) W 1P O PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, C12Q 1/68 (2018.01) A61P 31/18 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, C12Q 1/70 (2006.01) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (21) International Application Number: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, PCT/US2018/056167 OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (22) International Filing Date: SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 16 October 2018 (16. 10.2018) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (26) Publication Language: English GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (30) Priority Data: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 62/573,025 16 October 2017 (16. 10.2017) US TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, ΓΕ , IS, IT, LT, LU, LV, (71) Applicant: MASSACHUSETTS INSTITUTE OF MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TECHNOLOGY [US/US]; 77 Massachusetts Avenue, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Cambridge, Massachusetts 02139 (US).
    [Show full text]
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
    [Show full text]
  • C/Ebpδ Targets Cyclin D1 for Proteasome-Mediated Degradation Via Induction of CDC27/APC3 Expression
    C/EBPδ targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression Snehalata A. Pawara,1,2, Tapasree Roy Sarkara,2, Kuppusamy Balamurugana, Shikha Sharana, Jun Wanga, Youhong Zhanga, Steven F. Dowdyb, A-Mei Huanga,3, and Esta Sternecka,4 aCenter for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201; and bDepartment of Cellular and Molecular Medicine, Howard Hughes Medical Institute, University of California, San Diego School of Medicine, La Jolla, CA 92093-0686 Edited* by George F. Vande Woude, Van Andel Research Institute, Grand Rapids, MI, and approved April 15, 2010 (received for review December 3, 2009) The transcription factor CCAAT/enhancer binding protein δ (C/EBPδ, breast tumor cell lines including MCF-7 (16). Addressing the CEBPD, NFIL-6β) has tumor suppressor function; however, the molecu- possibility of a causal relationship, we found that exogenous lar mechanism(s) by which C/EBPδ exerts its effect are largely unknown. C/EBPδ alone down-regulated endogenous cyclin D1 but not Here, we report that C/EBPδ induces expression of the Cdc27 (APC3) cyclin E2 in MCF-7 cells (Fig. 1A). An inverse correlation of C/ subunit of the anaphase promoting complex/cyclosome (APC/C), which EBPδ and cyclin D1 protein expression was also observed in MEFs results in the polyubiquitination and degradation of the prooncogenic from wild-type and Cebpd null mice (Fig. S1A). Next, we tested the cell cycle regulator cyclin D1, and also down-regulates cyclin B1, Skp2, role of target gene regulation by introducing an R198A mutation andPlk-1.InC/EBPδ knockout mouse embryo fibroblasts (MEF) Cdc27 into the DNA binding domain (C/EBPδ-R198A), which does levels were reduced, whereas cyclin D1 levels were increased even in not affect nuclear localization (17) but prevents DNA binding of the presence of activated GSK-3β.
    [Show full text]
  • Protein Engineering of a Ubiquitin-Variant Inhibitor of APC/C Identifies a Cryptic K48 Ubiquitin Chain Binding Site
    Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding site Edmond R. Watsona,b, Christy R. R. Gracea, Wei Zhangc,d,2, Darcie J. Millera, Iain F. Davidsone, J. Rajan Prabub, Shanshan Yua, Derek L. Bolhuisf, Elizaveta T. Kulkof, Ronnald Vollrathb, David Haselbache,g, Holger Starkg, Jan-Michael Peterse,h, Nicholas G. Browna,f, Sachdev S. Sidhuc,1, and Brenda A. Schulmana,b,1 aDepartment of Structural Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105; bDepartment of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany; cDonnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, Canada M5S3E1; dDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada M5S3E1; eResearch Institute of Molecular Pathology, Vienna BioCenter, 1030 Vienna, Austria; fDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599; gMax Planck Institute for Biophysical Chemistry, 37077 Göttingen, Germany; and hMedical University of Vienna, 1090 Vienna, Austria Contributed by Brenda A. Schulman, June 24, 2019 (sent for review February 19, 2019; reviewed by Kylie Walters and Hao Wu) Ubiquitin (Ub)-mediated proteolysis is a fundamental mechanism the type of catalytic domain. E3s harboring “HECT” and “RBR” used by eukaryotic cells to maintain homeostasis and protein catalytic domains promote ubiquitylation through 2-step reac- quality, and to control timing in biological processes. Two essential tions involving formation of a thioester-linked intermediate be- aspects of Ub regulation are conjugation through E1-E2-E3 enzy- tween the E3 and Ub’s C terminus: First, Ub is transferred from matic cascades and recognition by Ub-binding domains.
    [Show full text]
  • Ultraconserved Elements Are Associated with Homeostatic Control of Splicing Regulators by Alternative Splicing and Nonsense-Mediated Decay
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay Julie Z. Ni,1 Leslie Grate,1 John Paul Donohue,1 Christine Preston,2 Naomi Nobida,2 Georgeann O’Brien,2 Lily Shiue,1 Tyson A. Clark,3 John E. Blume,3 and Manuel Ares Jr.1,2,4 1Center for Molecular Biology of RNA and Department of Molecular, Cell, and Developmental Biology, University of California at Santa Cruz, Santa Cruz, California 95064, USA; 2Hughes Undergraduate Research Laboratory, University of California at Santa Cruz, Santa Cruz, California 95064, USA; 3Affymetrix, Inc., Santa Clara, California 95051, USA Many alternative splicing events create RNAs with premature stop codons, suggesting that alternative splicing coupled with nonsense-mediated decay (AS-NMD) may regulate gene expression post-transcriptionally. We tested this idea in mice by blocking NMD and measuring changes in isoform representation using splicing-sensitive microarrays. We found a striking class of highly conserved stop codon-containing exons whose inclusion renders the transcript sensitive to NMD. A genomic search for additional examples identified >50 such exons in genes with a variety of functions. These exons are unusually frequent in genes that encode splicing activators and are unexpectedly enriched in the so-called “ultraconserved” elements in the mammalian lineage. Further analysis show that NMD of mRNAs for splicing activators such as SR proteins is triggered by splicing activation events, whereas NMD of the mRNAs for negatively acting hnRNP proteins is triggered by splicing repression, a polarity consistent with widespread homeostatic control of splicing regulator gene expression.
    [Show full text]
  • A Novel Function for HSF1-Induced Mitotic Exit Failure and Genomic Instability Through Direct Interaction Between HSF1 and Cdc20
    Oncogene (2008) 27, 2999–3009 & 2008 Nature Publishing Group All rights reserved 0950-9232/08 $30.00 www.nature.com/onc ORIGINAL ARTICLE A novel function for HSF1-induced mitotic exit failure and genomic instability through direct interaction between HSF1 and Cdc20 YJ Lee1, HJ Lee1, JS Lee2, D Jeoung3, CM Kang1, S Bae1, SJ Lee2, SH Kwon4, D Kang4 and YS Lee1 1Division of Radiation Effect, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; 2Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; 3College of Natural Sciences, Kangwon National University, Chunchon, Korea and 4Korea Basic Science Institute, Chunchon Center, Chunchon, Korea Although heat-shock factor (HSF) 1 is a known highly aneuploid, however, the molecular mechanisms transcriptional factor of heat-shock proteins, other path- underlying the development of aneuploidy have not wayslike production of aneuploidy and increasedprotein been fully defined, although mutations in mitotic stability of cyclin B1 have been proposed. In the present checkpoint genes have been identified in a subset of study, the regulatory domain of HSF1 (amino-acid human cancers and cell lines (Lengauer et al., 1997; sequence 212–380) was found to interact directly with Cahill et al., 1998). the amino-acid sequence 106–171 of Cdc20. The associa- Enhanced heat-shock protein (HSP) expression in tion between HSF1 and Cdc20 inhibited the interaction response to various stimuli is regulated by heat-shock between Cdc27 and Cdc20, the phosphorylation of Cdc27 factors (HSFs), the functional relevance of which is now and the ubiquitination activity of anaphase-promoting emerging.
    [Show full text]
  • An Architectural Map of the Anaphase-Promoting Complex
    Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press An architectural map of the anaphase-promoting complex Brian R. Thornton,1,3 Tessie M. Ng,1,3 Mary E. Matyskiela,2 Christopher W. Carroll,2 David O. Morgan,2 and David P. Toczyski1,4 1Cancer Research Institute, Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California 94115, USA; 2Department of Physiology, University of California, San Francisco, California 94143-2200, USA The anaphase-promoting complex or cyclosome (APC) is an unusually complicated ubiquitin ligase, composed of 13 core subunits and either of two loosely associated regulatory subunits, Cdc20 and Cdh1. We analyzed the architecture of the APC using a recently constructed budding yeast strain that is viable in the absence of normally essential APC subunits. We found that the largest subunit, Apc1, serves as a scaffold that associates independently with two separable subcomplexes, one that contains Apc2 (Cullin), Apc11 (RING), and Doc1/Apc10, and another that contains the three TPR subunits (Cdc27, Cdc16, and Cdc23). We found that the three TPR subunits display a sequential binding dependency, with Cdc27 the most peripheral, Cdc23 the most internal, and Cdc16 between. Apc4, Apc5, Cdc23, and Apc1 associate interdependently, such that loss of any one subunit greatly reduces binding between the remaining three. Intriguingly, the cullin and TPR subunits both contribute to the binding of Cdh1 to the APC. Enzymatic assays performed with APC purified from strains lacking each of the essential subunits revealed that only cdc27⌬ complexes retain detectable activity in the presence of Cdh1.
    [Show full text]